Form 4: GoHealth COO Mike Hargis Reports Stock Transactions
SEC Form 4 Filing
GoHealth's Chief Operating Officer, Mike Hargis, reports the acquisition and disposal of Class A Common Stock, including shares withheld for tax obligations and a grant of restricted stock units.
Summary
- Mike Hargis, the Chief Operating Officer of GoHealth, Inc., filed a Form 4 detailing changes in beneficial ownership.
- On April 1, 2025, Hargis disposed of 8,317 shares of Class A Common Stock at a price of $12.39 per share to cover tax withholding obligations related to vesting restricted stock units.
- On the same date, Hargis acquired 100,000 shares of Class A Common Stock through a grant of restricted stock units at a price of $0.
- Following these transactions, Hargis directly owns 330,538 shares of Class A Common Stock.
- The restricted stock units vest in three substantially equal annual installments, starting on April 1, 2026.
Sentiment
Score: 6
Explanation: The sentiment is neutral as the filing primarily reports routine stock transactions related to executive compensation and tax obligations. There's no indication of significant positive or negative news.
Positives
- The grant of 100,000 restricted stock units to the COO could be seen as an incentive to drive future performance.
Future Outlook
The restricted stock units vest in three substantially equal annual installments, with the first such annual installment vesting on April 1, 2026, suggesting a multi-year incentive structure for the COO.
Industry Context
Executive stock transactions are common and are often used to align management's interests with those of shareholders. The vesting schedule of the restricted stock units encourages long-term commitment.
Comparison to Industry Standards
- Stock-based compensation is a common practice in the tech and healthcare industries, often used to attract and retain top talent.
- Companies like UnitedHealth Group (UNH) and Anthem (ANTM) also utilize stock options and restricted stock units as part of their executive compensation packages.
- The vesting schedule of three years is fairly standard, aligning with typical industry practices for long-term incentives.
Stakeholder Impact
- The stock transactions may have a minor impact on shareholders due to the change in ownership, but the overall effect is likely minimal.
Key Dates
| Date | Description |
|---|---|
| April 1, 2024 | Date of original grant of 33,333 restricted stock units. |
| April 1, 2025 | Date of stock disposal for tax withholding and grant of 100,000 restricted stock units. |
| April 1, 2026 | First vesting date for the newly granted restricted stock units. |
Keywords
Form 4, GoHealth, GOCO, Mike Hargis, Chief Operating Officer, Stock Transaction, Restricted Stock Units, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.